The continuing global challenges of treating patients with beta-thalassemia

In this issue, Hokland et al. offer an interesting view of the different approaches on how to treat a beta-thalassemia patient. The principal concerns, that this report reveals, are the very wide differences in the facilities and economic resources available for the care of patients. Management of thalassemia should become a word wide health care priority and may include at last those two steps: national and international registries; national programs for screening couples at risk and providing preventive measures to prevent births of patients with thalassemia. Commentary on: Hokland et al. Thalassemia: Global view. Br J Haematol 2022 (Online ahead of print). doi: 10.1111/bjh.18671.

Automated summary

This article discusses different approaches to treating beta-thalassemia patients. The report highlights significant differences in facilities and economic resources available for patient care, which is a major concern. Managing thalassemia should be a global healthcare priority, which may involve establishing national and international registries, as well as implementing national programs for screening at-risk couples and providing preventive measures to prevent the birth of thalassemia patients.